• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Churg-Strauss 综合征患者气道中白细胞介素-5 的产生增加和优势 Th2 型反应。

Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.

机构信息

Department of Medicine, Jagiellonian University Medical College, ul. Skawinska 8, 31-066 Krakow, Poland.

出版信息

Rheumatology (Oxford). 2012 Oct;51(10):1887-93. doi: 10.1093/rheumatology/kes171. Epub 2012 Jul 5.

DOI:10.1093/rheumatology/kes171
PMID:22772323
Abstract

OBJECTIVE

Churg-Strauss syndrome (CSS) is a rare systemic vasculitis associated with eosinophilia and asthma. We assessed the local immune response in airways of CSS patients with different activity of the disease.

METHODS

Concentration of IL-5, CCL17, CCL22 and CCL26 (ELISA) together with cell expression of T-helper-related genes (real-time PCR array) were measured in bronchoalveolar lavage fluid (BALF) sampled from 11 patients with active CSS, 11 patients with CSS in remission and 9 control subjects with bronchial asthma.

RESULTS

In active CSS, both BALF and blood eosinophil counts were increased (P<0.01). BALF cells in active disease were characterized by an increased expression of Th2 and regulatory-type transcripts: STAT6, STAT3, GATA3, IL4, IL5 and IL10 as compared with asthmatics, and STAT5A, CCR4, FOXP3, IL4, IL5 and IL10 when compared with inactive CSS. There was significant increase in BALF concentration of IL-5 and CCL26 in exacerbation of CSS. CCR4-active chemokines were detected more frequently in active disease. We found a strong positive correlation between clinical parameters of disease activity (BVAS, eosinophilia) and expression of IL4, IL5, IL10 and STAT5A.

CONCLUSION

These results indicate that as compared with asthma, active-CSS patients have much stronger local Th2 response in the airways. Airway cells may contribute to lung eosinophilia in CSS by producing IL-5 and eosinophil active chemokines.

摘要

目的

变应性肉芽肿性血管炎(CSS)是一种罕见的与嗜酸性粒细胞增多和哮喘相关的系统性血管炎。我们评估了不同疾病活动度的 CSS 患者气道中的局部免疫反应。

方法

采用 ELISA 法检测支气管肺泡灌洗液(BALF)中 IL-5、CCL17、CCL22 和 CCL26 的浓度,并采用实时 PCR 阵列法检测 BALF 中 T 辅助相关基因的细胞表达,共纳入 11 例活动期 CSS 患者、11 例缓解期 CSS 患者和 9 例支气管哮喘对照者。

结果

在活动期 CSS 患者中,BALF 和血液嗜酸粒细胞计数均升高(P<0.01)。与哮喘患者相比,活动期疾病的 BALF 细胞表现出 Th2 和调节型转录物的表达增加:STAT6、STAT3、GATA3、IL4、IL5 和 IL10;与缓解期 CSS 相比,STAT5A、CCR4、FOXP3、IL4、IL5 和 IL10 也增加。CSS 恶化时 BALF 中 IL-5 和 CCL26 的浓度显著增加。在活动期疾病中,CCR4 活性趋化因子更频繁地被检测到。我们发现疾病活动的临床参数(BVAS、嗜酸性粒细胞增多)与 IL4、IL5、IL10 和 STAT5A 的表达之间存在强烈的正相关。

结论

与哮喘相比,活动期 CSS 患者的气道中 Th2 反应更强。气道细胞可能通过产生 IL-5 和嗜酸性粒细胞活性趋化因子导致 CSS 肺嗜酸性粒细胞增多。

相似文献

1
Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.Churg-Strauss 综合征患者气道中白细胞介素-5 的产生增加和优势 Th2 型反应。
Rheumatology (Oxford). 2012 Oct;51(10):1887-93. doi: 10.1093/rheumatology/kes171. Epub 2012 Jul 5.
2
Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.Th2 和 Th17 反应均参与变应性肉芽肿性血管炎的发病机制。
Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S23-34. Epub 2011 May 11.
3
Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.变应性肉芽肿性血管炎外周血嗜酸性粒细胞凋亡的内源性途径
Rheumatology (Oxford). 2009 Oct;48(10):1202-7. doi: 10.1093/rheumatology/kep209. Epub 2009 Jul 29.
4
Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.嗜酸性粒细胞趋化因子-3与变应性肉芽肿性血管炎相关——一种与疾病活动密切相关的血清标志物。
Rheumatology (Oxford). 2008 Jun;47(6):804-8. doi: 10.1093/rheumatology/ken033. Epub 2008 Apr 8.
5
Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.调节性T细胞在变应性肉芽肿性血管炎发病机制中的作用
Int Arch Allergy Immunol. 2008;146 Suppl 1:73-6. doi: 10.1159/000126065. Epub 2008 May 27.
6
Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.变应性肉芽肿性血管炎中的促炎细胞因子与自身免疫
Ann N Y Acad Sci. 2005 Jun;1051:121-31. doi: 10.1196/annals.1361.053.
7
Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17.活动性变应性肉芽肿性血管炎患者CD4 + T细胞的细胞因子产生谱倾向于Th17。
Int Arch Allergy Immunol. 2009;149 Suppl 1:61-5. doi: 10.1159/000210656. Epub 2009 Jun 3.
8
12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome.12-羟基二十碳四烯酸(12-HETE):变应性肉芽肿性血管炎的生物标志物。
Clin Exp Allergy. 2012 Apr;42(4):513-22. doi: 10.1111/j.1365-2222.2011.03943.x.
9
Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.变应性肉芽肿性血管炎与哮喘性慢性嗜酸性粒细胞性肺炎之间调节性T细胞的差异。
J Allergy Clin Immunol. 2008 Sep;122(3):610-6. doi: 10.1016/j.jaci.2008.05.040. Epub 2008 Jun 30.
10
CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.Churg-Strauss综合征中的CCL17/胸腺与活化相关趋化因子
Arthritis Rheum. 2010 Nov;62(11):3496-503. doi: 10.1002/art.27678.

引用本文的文献

1
The management of type 2 inflammatory respiratory diseases: a Chinese expert consensus [2024].2型炎症性呼吸道疾病的管理:中国专家共识[2024年]
J Thorac Dis. 2025 Apr 30;17(4):1807-1831. doi: 10.21037/jtd-2024-2092. Epub 2025 Mar 25.
2
Improving patient outcomes: Mepolizumab's impact in IL-5-mediated diseases.改善患者预后:美泊利珠单抗在白细胞介素-5介导疾病中的作用
Lung India. 2025 May 1;42(3):231-244. doi: 10.4103/lungindia.lungindia_442_24. Epub 2025 Apr 29.
3
A case of eosinophilic granulomatosis with polyangiitis with human immunodeficiency virus as the underlying etiology.
一例以人类免疫缺陷病毒为潜在病因的嗜酸性肉芽肿性多血管炎病例。
Arch Rheumatol. 2025 Mar 17;40(1):125-127. doi: 10.46497/ArchRheumatol.2025.10920. eCollection 2025 Mar.
4
Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitis.嗜酸性肉芽肿性多血管炎的异质性与个体化治疗
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251318615. doi: 10.1177/17534666251318615.
5
Solo Addition of Mepolizumab Turned Antineutrophil Cytoplasmic Antibody Negative and Achieved Glucocorticoid Discontinuation in a Patient with Eosinophilic Granulomatosis with Polyangiitis.在一名嗜酸性肉芽肿性多血管炎患者中,单独添加美泊利珠单抗使抗中性粒细胞胞浆抗体转阴并实现了糖皮质激素停用。
Intern Med. 2025 May 1;64(9):1423-1426. doi: 10.2169/internalmedicine.4130-24. Epub 2024 Oct 4.
6
Three cases of relapsed eosinophilic sinusitis without eosinophilia during mepolizumab maintenance therapy for eosinophilic granulomatosis with polyangiitis.例三为嗜酸性粒细胞性肉芽肿伴多血管炎患者在美泊利单抗维持治疗期间出现复发性无嗜酸性粒细胞性鼻旁窦炎。
Clin Rheumatol. 2024 Nov;43(11):3577-3580. doi: 10.1007/s10067-024-07133-w. Epub 2024 Sep 9.
7
The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review.嗜酸性粒细胞增多症及嗜酸性粒细胞疾病的诊断与分类挑战:综述
Cent Eur J Immunol. 2024;49(1):60-69. doi: 10.5114/ceji.2024.136512. Epub 2024 Apr 19.
8
Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and Anti-SCR HIV-1 Effects.靶向 Nef-Tat 融合抗原的异源 DNA 初免/蛋白加强免疫诱导强烈的 T 细胞活性和抗 SCR HIV-1 作用。
Curr HIV Res. 2024;22(2):109-119. doi: 10.2174/011570162X297602240430142231.
9
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.抗白细胞介素-5/受体α 生物制剂治疗嗜酸性肉芽肿伴多血管炎的疗效和安全性:一项为期两年的多中心观察性研究。
Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023.
10
Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment.嗜酸性肉芽肿性多血管炎——发病机制、诊断及治疗的进展
Front Med (Lausanne). 2023 May 3;10:1145257. doi: 10.3389/fmed.2023.1145257. eCollection 2023.